When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

High altitude illness

Última revisão: 17 Aug 2025
Última atualização: 26 Oct 2023

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • headache
  • ataxia
  • change in mental state: for example, tired, irritable, confused, forgetful, irrational
  • abnormal tone, power, and reflexes
Detalhes completos

Outros fatores diagnósticos

  • nausea, vomiting, and loss of appetite
  • fatigue and weakness
  • dizziness or lightheadedness
  • difficulty sleeping
  • visual disturbance
  • shortness of breath
  • cough with or without sputum
  • rales
  • peripheral edema
  • accentuated pulmonary second sound
  • pyrexia
  • elevated respiratory rate
  • elevated heart rate
  • low arterial oxygen saturation
  • cyanosis
  • urinary incontinence or retention
  • retinal hemorrhages and papilledema on fundoscopy
  • chest pain
  • cranial nerve palsies (III, IV, and VI)
  • visual and auditory hallucinations, seizures, tinnitus, vertigo, tremors, speech disturbance, and deafness
Detalhes completos

Fatores de risco

  • high altitude
  • rapid ascent
  • low-altitude residence
  • history of previous altitude illness
  • younger age
  • exertion
  • poor awareness of high-altitude illness prior to travel
  • existing medical condition
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • clinical diagnosis
Detalhes completos

Investigações a serem consideradas

  • arterial blood gases
  • chest radiography
  • ECG
  • chest ultrasound and echocardiography
  • WBC count
  • lumbar puncture
  • CT head
  • MRI head
Detalhes completos

Algoritmo de tratamento

Inicial

high-altitude ascent planned

AGUDA

AMS

HAPE only

HACE only

concurrent HAPE and HACE

Colaboradores

Autores

Jeremy S. Windsor, MBChB, DCH, FCARCSI

Specialist Registrar

Anaesthetics and Intensive Care Medicine

University College Hospital

London

UK

Declarações

JSW is an author of a number of references cited in this topic.

Revisores

James S. Milledge, MBBS

Honorary Professor

Department of Physiology

University College London

London

UK

Declarações

JSM declares that he has no competing interests.

Mike Grocott, MD

Senior Lecturer

Intensive Care Medicine

University College Hospital

London

UK

Declarações

MG declares that he has no competing interests.

Haibo Wang, MD, PhD

Assistant Professor

LSU Health Sciences Center

Shreveport

LA

Declarações

HW declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 4: environmental hazards & risks - high elevation travel & altitude illness. May 2023 [internet publication].Texto completo

Roach RC, Hackett PH, Oelz O, et al. The 2018 lake louise acute mountain sickness score. High Alt Med Biol. 2018 Mar;19(1):4-6.Texto completo  Resumo

Luks AM, Auerbach PS, Freer L, et al. Wilderness medical society clinical practice guidelines for the prevention and treatment of acute altitude illness: 2019 update. Wilderness Environ Med. 2019 Dec;30(4s):S3-18.Texto completo  Resumo

Donegani E, Paal P, Küpper T, et al. Drug use and misuse in the mountains: a UIAA MedCom consensus guide for medical professionals. High Alt Med Biol. 2016 Sep;17(3):157-84. Resumo

Ritchie ND, Baggott AV, Andrew Todd WT. Acetazolamide for the prevention of acute mountain sickness - a systematic review and meta-analysis. J Travel Med. 2012 Sep-Oct;19(5):298-307.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • High altitude illness images
  • Diagnósticos diferenciais

    • Asthma, acute exacerbation
    • Community-acquired pneumonia
    • Acute exacerbation of chronic heart failure (CHF)
    Mais Diagnósticos diferenciais
  • Diretrizes

    • CDC Yellow Book: health information for international travel - high elevation travel & altitude illness
    • Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2019 update​
    Mais Diretrizes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal